ArticleClinical pharmacokinetics2020

Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus.

Ahmed Nader et al.PubMed ↗Publisher ↗

No numbers read from the abstract.